Bharat Biotech‘s Covid-19 vaccine Covaxin was recommended by an expert panel for phase II/III clinical trial on those aged between 2 to 18 years, said official sources. The trial will take place on 525 subjects at various sites, including AIIMS, Delhi; AIIMS, Patna; and Meditrina Institute of Medical Sciences, Nagpur. The nod from the Subject … Continue reading Bharat BioTech’s Covaxin gets nod for trial on children aged 2-18 years